Defronzo RA - Search Results

1

Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals.

Matsuda M, Defronzo RA, Glass L, Consoli A, Giordano M, Bressler P, Delprato S. Matsuda M, et al. Among authors: defronzo ra. Metabolism. 2002 Sep;51(9):1111-9. doi: 10.1053/meta.2002.34700. Metabolism. 2002. PMID: 12200754 Clinical Trial.

2

Effects of insulin on subcellular localization of hexokinase II in human skeletal muscle in vivo.

Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Pendergrass M, Koval J, Ardehali H, Printz R, Granner D, Defronzo R, Mandarino L. Vogt C, et al. J Clin Endocrinol Metab. 1998 Jan;83(1):230-4. doi: 10.1210/jcem.83.1.4476. J Clin Endocrinol Metab. 1998. PMID: 9435447

3

Regulation of hexokinase II expression in human skeletal muscle in vivo.

Vogt C, Ardehali H, Iozzo P, Yki-Järvinen H, Koval J, Maezono K, Pendergrass M, Printz R, Granner D, DeFronzo R, Mandarino L. Vogt C, et al. Metabolism. 2000 Jun;49(6):814-8. doi: 10.1053/meta.2000.6245. Metabolism. 2000. PMID: 10877213 Clinical Trial.

4

Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.

Cusi K, DeFronzo R. Cusi K, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3077-84. doi: 10.1210/jcem.85.9.6827. J Clin Endocrinol Metab. 2000. PMID: 10999789 Clinical Trial.

5

Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes.

Pratipanawatr T, Cusi K, Ngo P, Pratipanawatr W, Mandarino LJ, DeFronzo RA. Pratipanawatr T, et al. Among authors: defronzo ra. Diabetes. 2002 Feb;51(2):462-8. doi: 10.2337/diabetes.51.2.462. Diabetes. 2002. PMID: 11812756

6

Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.

Miyazaki Y, Matsuda M, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Diabetes Care. 2002 Mar;25(3):517-23. doi: 10.2337/diacare.25.3.517. Diabetes Care. 2002. PMID: 11874940 Clinical Trial.

7

Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA. Pratipanawatr T, et al. Among authors: defronzo ra. Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8. doi: 10.1152/ajpendo.00335.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12006367 Free article.

8

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91. doi: 10.1210/jcem.87.6.8567. J Clin Endocrinol Metab. 2002. PMID: 12050251

9

Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans.

Bajaj M, Berria R, Pratipanawatr T, Kashyap S, Pratipanawatr W, Belfort R, Cusi K, Mandarino L, DeFronzo RA. Bajaj M, et al. Among authors: defronzo ra. Am J Physiol Endocrinol Metab. 2002 Aug;283(2):E346-52. doi: 10.1152/ajpendo.00329.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12110541 Free article.

10

Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA. Bajaj M, et al. Among authors: defronzo ra. Diabetes. 2002 Oct;51(10):3043-8. doi: 10.2337/diabetes.51.10.3043. Diabetes. 2002. PMID: 12351445 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

669 results

Search Page